Cointime update: Fosun Pharma chairman Chen Yuqing has proposed a buyback of the company’s A-shares through centralized bidding, with total funds of no less than RMB 250 million and no more than RMB 500 million. The repurchase price would not exceed 150% of the average price over the 30 trading days before the board approves the plan. The buyback, valid for up to 12 months, would fund convertible bond conversion, equity incentives and/or employee stock ownership plans.
Fosun Pharma Chairman Proposes RMB 250-500M A-Share Buyback
Share on WeChat
Open WeChat → Scan → then tap "…" to send to a chat or Moments.
Tap "…" in the top-right corner to send to a chat or share to Moments.
Related News
2h ago
Anthropic Expected to Price IPO Above Range at $80+ Per Share
3h ago
Ark Invest Buys $2.7M of Block Shares as Stock Falls 4.4%
3h ago
Nvidia beats estimates; NVDA perp on Hyperliquid rises 4% to $161.7
4h ago
Anthropic Existing Investors Plan Billions in IPO Share Purchase
5h ago
Analyst: Nvidia’s core business solid, AI infrastructure demand supports guidance
6h ago
SEC Opens Civil Probe Into Nvidia Over Investor Disclosures